CurrentUnitedHealthcarePolicy CS107PA.AD

Rhinoplasty Other Nasal Surgeries Pa Cs

UnitedHealthcare Pennsylvania-specific medical policy CS107PA.AD describing coverage criteria, definitions, applicable CPT/HCPCS codes, descriptions of services, statements of unproven procedures, and supporting evidence for rhinoplasty and other nasal surgeries.

Policy Summary

PayerUnitedHealthcare

PolicyRhinoplasty Other Nasal Surgeries Pa Cs

Policy CodePolicy CS107PA.AD

Change TypeRemoved code 30999text updates

Effective DateJun 1, 2025

Next Review Date

Key ActionSurgeon must document valve compromise characteristics, photos demonstrating collapse/deformity consistent with exam, and a clear surgical plan including need for cartilage graft.

SourceLink

POLICY UPDATE CHANGES

Removed CPT code 30999 from Applicable Codes.

Updated Description of Services, Clinical Evidence, and References sections to reflect current information.

MultipleReferenced procedure codes

4Main covered procedure categories

4Unproven procedures listed

multipleRCTs reported

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

limitedQuality of evidence (general)

Coverage Summary

Overview: UnitedHealthcare Medical Policy CS107PA.AD (Effective 2025-06-01) applies to Pennsylvania only and defines coverage criteria for rhinoplasty and other nasal procedures. The policy distinguishes reconstructive (medically necessary) indications from cosmetic procedures and identifies key covered procedure categories, including nasal valve procedures/repair of nasal vestibular stenosis or alar collapse, rhinophyma excision, rhinoplasty for congenital anomalies, and primary rhinoplasty.

Key thresholds and quick facts

Conservative management duration (rhinoplasty-primary/revision/tip)4 weeks or greater

Conservative management duration (Prolonged, Persistent Nasal Airway Obstruction definition)6 weeks of medical management

Number of main covered categories4

Unproven procedures listed (count)4

Code removed (per 06/01/2025)CPT 30999

Evidence quality noteLimited (overall low to moderate quality; many single-arm studies and short-term follow-up)

Medical-Necessity Criteria

Nasal valve procedures/repair of nasal vestibular stenosis or alar collapse - Medically Necessary

Covered when ALL of the following criteria are present:

ALL of the following

ALL of the following
- Prolonged, Persistent Obstructed nasal breathing due to internal and/or External Nasal Valve compromise
- Nasal septal deviation and turbinate hypertrophy
  - Nasal septal deviation and turbinate hypertrophy — options: Are not present
  - Nasal septal deviation and turbinate hypertrophy — options:

Not Medically Necessary / Unproven Procedures

Unproven / Not Medically Necessary

The following procedures are considered unproven and not medically necessary due to insufficient evidence of safety and/or efficacy:

Unproven / Not Medically Necessary: Absorbable polylactic acid nasal cartilage support implants (e.g., Latera Absorbable Nasal Implant)

Unproven / Not Medically Necessary: Nasal septal swell body (NSB) reduction for the treatment of nasal obstruction

Unproven / Not Medically Necessary: Posterior nasal nerve or sphenopalatine ganglion ablation using any method (radiofrequency or cryoablation; e.g., RhinAer, ClariFix) for chronic rhinitis

Unproven / Not Medically Necessary: Radiofrequency treatment of nasal valves for treatment of Nasal Airway Obstruction (e.g., VivAer ARC Stylus)

Coding

Billing Rule

Coding review advisory

All nasal surgical claims may be subject to coding review; listed codes may be cosmetic and require review to determine reconstructive vs cosmetic classification.

CPT codes: 30400, 30410, 30420, 30430, 30435, 30450, 30460, 30462, 30465, 30466, 30999
HCPCS: L8699
FDA/device references: LRC (Latera Absorbable Nasal Implant), LYA (VivAer/other devices)

Provider Actions & Documentation Requirements

Documentation Required

Preoperative documentation required

Surgeon must document the nature of valve compromise (static vs dynamic), whether internal and/or external valve is involved, photos demonstrating collapse or deformity consistent with exam, and a clear surgical plan including the need for a cartilage graft.

Nature of valve compromise (static vs dynamic)
Internal and/or External Nasal Valve involvement
Photographs documenting dynamic collapse or anatomic deformity consistent with exam
Clear surgical plan including indication for cartilage graft

Documentation Required

Conservative therapy trial requirement

Obstructive symptoms for rhinoplasty-primary, revision, or tip must persist despite conservative management for 4 weeks or greater (including nasal steroids or immunotherapy where appropriate); the definition of Prolonged, Persistent Nasal Airway Obstruction requires six weeks of medical management. See policy thresholds for exact values.

Background, Definitions & Evidence Summary

Background: This Pennsylvania-specific policy is intended to define reconstructive versus cosmetic indications for nasal surgeries, provide definitions (for example, Mechanical Nasal Airway Obstruction and Prolonged, Persistent Nasal Airway Obstruction), describe covered services and applicable codes, and note that certain procedures (such as absorbable polylactic acid implants, septal swell body reduction, posterior nasal nerve or sphenopalatine ganglion ablation, and radiofrequency valve treatments) are considered unproven.

Key definitions

Key evidence summary

Revision History

06/01/2025material_changeLatest

Summary of Changes dated 06/01/2025: Removed CPT code 30999 from Applicable Codes; updated Description of Services, Clinical Evidence, and References sections.

06/01/2025archived_version_note

Archived previous policy version CS107PA.AC.

Policy Summary

PayerUnitedHealthcare

PolicyRhinoplasty Other Nasal Surgeries Pa Cs

Policy CodePolicy CS107PA.AD

Change TypeRemoved code 30999text updates

Effective DateJun 1, 2025

Next Review Date

Key ActionSurgeon must document valve compromise characteristics, photos demonstrating collapse/deformity consistent with exam, and a clear surgical plan including need for cartilage graft.

SourceLink

On This Page

Have been previously surgically treated

Nasal septal deviation and turbinate hypertrophy — options: Are scheduled to be surgically treated at the same time as the nasal valve procedure/repair as part of the surgery plan

Documented evidence of visible collapse of the alar (lower lateral) cartilage (External Nasal Valve) and/or lateral nasal wall (internal nasal valve) with deep inspiration

Documented evidence of subjective and audible improvement in nasal airflow during modified Cottle maneuver

Photos clearly document either dynamic collapse of the internal and/or External Nasal Valve or anatomic deformities narrowing the internal and/or External Nasal Valve as a main cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam

Surgeon description: The surgeon has clearly described whether the nasal valve compromise is static or dynamic

Surgeon description: The surgeon has clearly described whether the nasal valve compromise involves internal nasal valve, External Nasal Valve, or both

Surgical plan: A plainly stated and clear surgical plan including the need for a cartilage graft

Rhinophyma excision - Medically Necessary

Covered when ALL of the following criteria are present:

ALL of the following

Indications (ONE of)
- Prolonged, persistent obstructed nasal breathing due to rhinophyma
- Chronic infection or bleeding unresponsive to medical management due to rhinophyma
Photos clearly document rhinophyma as the primary cause of an anatomic Mechanical Nasal Airway Obstruction or chronic infection and are consistent with the clinical exam
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the Nasal Airway Obstruction by correcting the deformity or the proposed procedure is designed to address the chronic infection

Rhinoplasty for congenital anomalies - Medically Necessary

Covered when the following is present:

ALL of the following

Rhinoplasty is performed for a nasal deformity associated with congenital craniofacial anomalies (examples: Pierre Robin syndrome, Apert syndrome, Fraser syndrome, Binder syndrome, Goldenhar syndrome, nasal dermoids, Tessier nasal cleft, or associated with a cleft lip or cleft palate)

Rhinoplasty-primary - Medically Necessary

Covered when ALL of the following criteria are present:

ALL of the following

Indication (ONE of)
- Prolonged, Persistent Obstructed nasal breathing due to nasal bone and septal deviation that are the primary causes of an anatomic Mechanical Nasal Airway Obstruction
- Nasal fracture with nasal bone displacement severe enough to cause nasal airway obstruction
- Residual large cutaneous defect following resection of a malignancy or nasal trauma
The Nasal Airway Obstruction cannot be corrected by septoplasty alone as documented in the medical record
Photos clearly document the nasal bone/septal deviation as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the Nasal Airway Obstruction by centralizing the nasal bony pyramid and straightening the septum
Nasal Airway Obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing)
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Rhinoplasty-revision - Medically Necessary (exceptional)

Rhinoplasty-revision is primarily cosmetic but considered reconstructive and medically necessary when ALL of the following are present:

ALL of the following

Required as treatment of a complication/residual deformity from primary surgery performed to address a Functional Impairment when a documented Functional Impairment persists due to the complication/deformity
Photos clearly document the secondary deformity/complication as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by correcting the deformity or treating the complication
Nasal airway obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing)
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Rhinoplasty-tip - Medically Necessary (exceptional)

Rhinoplasty-tip is primarily cosmetic but considered reconstructive and medically necessary when ALL of the following are present:

ALL of the following

Prolonged, Persistent Obstructed nasal breathing due to tip drop that is the primary cause of an anatomic Mechanical Nasal Airway Obstruction
Photos clearly document tip drop as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam (acute columellar-labial angle)
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by lifting the nasal tip
Nasal airway obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing)
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Nasal polypectomy - Medically Necessary

Covered when criteria from InterQual CP: Procedures, Polypectomy, Nasal are met

Nasal polypectomy is considered reconstructive and medically necessary in certain circumstances; refer to InterQual CP criteria

Refer to InterQual Clinical Policy: Procedures, Polypectomy, Nasal

Evidence statement: The policy lists several items as unproven / not medically necessary due to insufficient evidence of safety and/or efficacy; this determination aligns with the summarized evidence assessments noting limited quality, short follow-up, and need for higher-quality comparative trials.

Rhinoplasty-primary/revision/tip conservative management duration: ≥4 weeks

Prolonged, Persistent Nasal Airway Obstruction definition: 6 weeks of medical management

Conservative therapies may include nasal steroids or immunotherapy where appropriate

Prior Authorization

Prior Authorization - Pennsylvania-specific

This Medical Policy only applies to the state of Pennsylvania. Any requests that do not meet PARP criteria will be evaluated case-by-case. Refer to Pennsylvania Exceptions, Pennsylvania Code Title 55, Chapter 1101.

Note

Study limitations and informed consent

Counsel patients that the available evidence is limited in quality, follow-up is often short-term, and adjunctive procedures in trials can confound outcomes when considering absorbable implants, NSB reduction, or posterior nasal nerve/spenopalatine ganglion ablation.

Documentation Required

Device indication documentation

Document the specific device used and confirm the device's FDA indication aligns with the intended procedural target (examples: ClariFix, RhinAer, VivAer, Latera, VivAer TCRF, etc.).

Record device model/brand used (e.g., Latera, ClariFix, RhinAer, VivAer)
Confirm FDA indication matches intended anatomical target (e.g., PNN region, internal nasal valve, lateral cartilage support)

Documentation Required

Reporting baseline scores & responder definitions

Document baseline symptom scores and responder definitions used in trials when reporting outcomes or assessing eligibility.

Baseline scores to document: NOSE, rTNSS/TNSS
Responder thresholds: ≥30% reduction in rTNSS/TNSS
Or: ≥20% reduction in NOSE score or ≥1 clinical severity class improvement

Note

Use of third-party criteria permitted

UnitedHealthcare may use third-party tools (e.g., InterQual) to assist in administering benefits; providers should be aware these tools may inform coverage decisions.